Bhupal
________________________________
From: Antibody Discussion Forum
<email obscured><email obscured>>> on behalf of
Bover,Laura <email obscured><email obscured>>>
Sent: Tuesday, September 24, 2019 6:37 PM
To: <email obscured><email obscured>>
<email obscured><email obscured>>>
Cc: Hawke,David H <email obscured><email obscured>>>;
Bover,Laura <email obscured><email obscured>>>
Subject: Re: [ABRF Ab Forum] [EXT] Epitope Mapping
MDAnderson has a Core facility to which I derive my customers that need epitope
mapping.
They don’t do the traditional overlapping peptides, but MS.
I cc here the Director of the Core David Hawke.
We should be able to do it with OCTET and peptides but we didn’t set up the
protocol yet.
Hope this helps.
Thanks
Laura
Laura Bover, PhD
Professor
Director Monoclonal Antibody Core Facility
University of Texas M.D.Anderson Cancer Center
Associate member of The University of Texas Graduate School of Biomedical
Sciences at Houston
Immunology Department/ Genomics Medicine Department
7455 Fannin St Room 1SCR4.3015/ 1901 East Rd- Room 4SCR5.1039
Houston- TX 77054
T 713-563-2281/ 713-563-3301
F 713-563-3276
<email obscured><email obscured>>
<email obscured>>
On 9/24/19, 1:57 PM, "Thomas White"
<email obscured><email obscured>>> wrote:
WARNING: This email originated from outside of MD Anderson. Please validate
the sender's email address before clicking on links or attachments as they may
not be safe.
We’ve used CovalX.
Best,
Tommy
Sent from my iPhone
> On Sep 24, 2019, at 2:23 PM, Christensen, Kurt Richard
<email obscured><email obscured>>> wrote:
>
> ― 1 file link ―
>
> Hi All,
> I have a customer that would like to have three mouse monoclonal
antibodies epitope mapped. Does anyone here offer epitope mapping as a
service? If so, please provide your contact information and I'll forward it
to them. I would also be open to companies that offer this service if anyone
has a recommendation, although I would like to send the work to a shared
resource first.
>
> Thanks in advance!
>
>
> Kurt
>
>
> Kurt Christensen
> Lab Director
> Protein and Monoclonal Antibody Production Core
>
> Web Page:
>
awbs://urldefense.proofpoint.com/v2/url?u=https-3A__www.bcm.edu_centers_cancer-2Dcenter_research_shared-2Dresources_antibody-2Dbased-2Dproteomics_recombinant-2Dprotein-2Dmonoclonal-2Dantibody&d=DwIFaQ&c=lb62iw4YL4RFalcE2hQUQealT9-RXrryqt9KZX2qu2s&r=0t4gvG5S4xJ4qh8QKA3DA2OcWGulGoAxklm2L3plckU&m=OlbDeqBtyV-C-5VeHAb6ElR5WD-4sheOivXB5RgORAQ&s=gvHtBZFltd8uyZ8g2NxQP0oycs7_GyvxdrGSVKpDDfY&e=
>
> iLab Requests:
>
awbs://urldefense.proofpoint.com/v2/url?u=https-3A__bcm.corefacilities.org_account_login&d=DwIFaQ&c=lb62iw4YL4RFalcE2hQUQealT9-RXrryqt9KZX2qu2s&r=0t4gvG5S4xJ4qh8QKA3DA2OcWGulGoAxklm2L3plckU&m=OlbDeqBtyV-C-5VeHAb6ElR5WD-4sheOivXB5RgORAQ&s=oSEcaUOTnBYHNu0MymyFlCuPlOOZjC5I1ISkAP-msZI&e=
>
> Office: 713-798-2325
> Lab:713-798-2327
> Email: <email obscured>
>
> Baylor College of Medicine
> Margaret M. Alkek Building for Biomedical Research, Room R551E, Mail Stop
BCM130
> 1 Baylor Plaza
> Houston, Texas 77030
>
>
>
>
>
>
> ― 1 file ―
>
> □ Picture (Device Independent Bitmap) 1.jpg (4.8kb)
>
awbs://urldefense.proofpoint.com/v2/url?u=http-3A__list.abrf.org_r_file_rxYBjECjRovjIxpB7R8K5MR2T8o-2D1ga-2D2LiGZj5_&d=DwIFaQ&c=lb62iw4YL4RFalcE2hQUQealT9-RXrryqt9KZX2qu2s&r=0t4gvG5S4xJ4qh8QKA3DA2OcWGulGoAxklm2L3plckU&m=OlbDeqBtyV-C-5VeHAb6ElR5WD-4sheOivXB5RgORAQ&s=mzwpvHl4kip6EUab7bTuMXc8cLnV1gl4ceh0Up9gd0A&e=
>
> ――
> View topic
awbs://urldefense.proofpoint.com/v2/url?u=http-3A__list.abrf.org_r_topic_D8AYEteHLPeIYdaGeHpgV&d=DwIFaQ&c=lb62iw4YL4RFalcE2hQUQealT9-RXrryqt9KZX2qu2s&r=0t4gvG5S4xJ4qh8QKA3DA2OcWGulGoAxklm2L3plckU&m=OlbDeqBtyV-C-5VeHAb6ElR5WD-4sheOivXB5RgORAQ&s=rR4dBVjEaEy_QDzQRUaCJ_qNHtntPej1Zs76vbV5lKE&e=
> Leave group <email obscured>?Subject=Unsubscribe
>
――
View topic awb://list.abrf.org/r/topic/dI0DK60jaL3aqPrOxWJCS
Leave group <email obscured>?Subject=Unsubscribe
The information contained in this e-mail message may be privileged,
confidential, and/or protected from disclosure. This e-mail message may contain
protected health information (PHI); dissemination of PHI should comply with
applicable federal and state laws. If you are not the intended recipient, or an
authorized representative of the intended recipient, any further review,
disclosure, use, dissemination, distribution, or copying of this message or any
attachment (or the information contained therein) is strictly prohibited. If
you think that you have received this e-mail message in error, please notify
the sender by return e-mail and delete all references to it and its contents
from your systems.
――
View topic awb://list.abrf.org/r/topic/W68jlLGzuZw9X5OIfRxCw
Leave group <email obscured>?Subject=Unsubscribe
The information contained in this e-mail message may be privileged,
confidential, and/or protected from disclosure. This e-mail message may contain
protected health information (PHI); dissemination of PHI should comply with
applicable federal and state laws. If you are not the intended recipient, or an
authorized representative of the intended recipient, any further review,
disclosure, use, dissemination, distribution, or copying of this message or any
attachment (or the information contained therein) is strictly prohibited. If
you think that you have received this e-mail message in error, please notify
the sender by return e-mail and delete all references to it and its contents
from your systems.
